|
|
|
30.04.25 - 09:48
|
GSK verdient zum Jahresauftakt überraschend viel (DPA-AFX)
|
|
LONDON (dpa-AFX) - Der britische Arzneimittelhersteller GSK (GlaxoSmithKline) hat im ersten Quartal sein schwaches Impfgeschäft durch einen florierenden Verkauf von Medikamenten gegen Krebs, Asthma und bei HIV ......
|
|
30.04.25 - 08:48
|
GSK Plc Q1 Results Rise; Confirms FY25 Outlook (AFX)
|
|
LONDON (dpa-AFX) - British drug maker GSK plc (GSK.L, GSK) reported Wednesday higher first-quarter profit and sales, and the company lifted quarterly dividend. Looking ahead, the company said it i......
|
|
|
|
05.02.25 - 15:15
|
GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares (RTTNews)
|
|
Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, after the British drug maker reported Wednesday a higher fourth-quarter results and issued positive outlook for fiscal 2025. The company further raised its sales view for fiscal 2031, and announced dividends and 2 billion pounds share buyback programme....
|
|
|
|
|
|
|
|
|
|
|
30.10.24 - 15:15
|
GSK Q3 Results Down, Sees FY24 Outlook At Mid Range; Stock Drops (RTTNews)
|
|
Shares of GSK plc were losing more than 4 percent on the London Stock Exchange as well as in the early morning trading on the NYSE after the British drug maker reported Wednesday sharply lower profit in its third quarter on $2.3 billion charge on Zantac settlement, as well as weak revenues. Further, GSK confirmed its fiscal 2024 outlook for earnings, core profit and sales....
|
|
|
|
|